# SGLT2i in Diabetic Patients with Renal Transplantation

> **NCT06731231** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 72 (actual)

## Conditions studied

- Post-transplant Diabetes Mellitus

## Interventions

- **DRUG:** SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT06731231
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-15
- **Primary completion:** 2024-12-15
- **Final completion:** 2025-01
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731231, "SGLT2i in Diabetic Patients with Renal Transplantation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06731231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*